Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaakov Dickstein

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Infection|June 16, 2025
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort studyYaakov Dickstein, Dafna Yahav, Giusy Tiseo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2021
A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to gram-negative pathogensAndrew Henderson, Evan Bursle, Adam Stewart, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 11, 2019
Antibiotic treatment for invasive nonpregnancy-associated listeriosis and mortality: a retrospective cohort studyYaakov Dickstein, Yonatan Oster, Orit Shimon, et al.
Viruses|December 31, 2025
Accessing HIV Care to Irregular Migrants in Israel, 2019-2024Tali Wagner, Zohar Mor, Yaakov Dickstein, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Microbiology Spectrum|May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumanniiHadas Kon, Amichay Hameir, Amir Nutman, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Infection|June 16, 2025
Carbapenemase type and mortality in blood-stream infections caused by carbapenemase-producing enterobacterales: a multicenter retrospective cohort studyYaakov Dickstein, Dafna Yahav, Giusy Tiseo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 4, 2021
A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to gram-negative pathogensAndrew Henderson, Evan Bursle, Adam Stewart, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 11, 2019
Antibiotic treatment for invasive nonpregnancy-associated listeriosis and mortality: a retrospective cohort studyYaakov Dickstein, Yonatan Oster, Orit Shimon, et al.
Viruses|December 31, 2025
Accessing HIV Care to Irregular Migrants in Israel, 2019-2024Tali Wagner, Zohar Mor, Yaakov Dickstein, et al.
Plos One|November 17, 2021
Risk factors for functional decline among survivors of Gram-negative bloodstream infection: A prospective cohort studyAdi Turjeman, Fidi Koppel, Erica Franceschini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2018
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical TrialYaakov Dickstein, Jonathan Lellouche, Maayan Ben Dalak Amar, et al.
Virulence|August 24, 2025
Virulence factors are preserved within carbapenem-resistant <i>Acinetobacter baumannii</i> cladesMor N Lurie-Weinberger, Adi Cohen, Hadas Kon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2019
Colistin Resistance Development Following Colistin-Meropenem Combination Therapy Versus Colistin Monotherapy in Patients With Infections Caused by Carbapenem-Resistant OrganismsYaakov Dickstein, Jonathan Lellouche, David Schwartz, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 12, 2018
Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled TrialDafna Yahav, Erica Franceschini, Fidi Koppel, et al.
Microbiology Spectrum|May 23, 2023
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumanniiHadas Kon, Amichay Hameir, Amir Nutman, et al.
Pageof 4